733 related articles for article (PubMed ID: 7872779)
1. Biochemical characterization of lauric acid omega-hydroxylation by a CYP4A1/NADPH-cytochrome P450 reductase fusion protein.
Chaurasia CS; Alterman MA; Lu P; Hanzlik RP
Arch Biochem Biophys; 1995 Feb; 317(1):161-9. PubMed ID: 7872779
[TBL] [Abstract][Full Text] [Related]
2. Effects of steric bulk and conformational rigidity on fatty acid omega hydroxylation by a cytochrome P450 4A1 fusion protein.
Bambal RB; Hanzlik RP
Arch Biochem Biophys; 1996 Oct; 334(1):59-66. PubMed ID: 8837739
[TBL] [Abstract][Full Text] [Related]
3. Heme-coordinating analogs of lauric acid as inhibitors of fatty acid omega-hydroxylation.
Lu P; Alterman MA; Chaurasia CS; Bambal RB; Hanzlik RP
Arch Biochem Biophys; 1997 Jan; 337(1):1-7. PubMed ID: 8990261
[TBL] [Abstract][Full Text] [Related]
4. Identification of CYP4A11 as the major lauric acid omega-hydroxylase in human liver microsomes.
Powell PK; Wolf I; Lasker JM
Arch Biochem Biophys; 1996 Nov; 335(1):219-26. PubMed ID: 8914854
[TBL] [Abstract][Full Text] [Related]
5. Characterization of the n-alkane and fatty acid hydroxylating cytochrome P450 forms 52A3 and 52A4.
Scheller U; Zimmer T; Kärgel E; Schunck WH
Arch Biochem Biophys; 1996 Apr; 328(2):245-54. PubMed ID: 8645001
[TBL] [Abstract][Full Text] [Related]
6. Omega- and (omega-1)-hydroxylation of lauric acid and arachidonic acid by rat renal cytochrome P-450.
Imaoka S; Tanaka S; Funae Y
Biochem Int; 1989 Apr; 18(4):731-40. PubMed ID: 2504167
[TBL] [Abstract][Full Text] [Related]
7. The kinetic and spectral characterization of the E. coli-expressed mammalian CYP4A7: cytochrome b5 effects vary with substrate.
Loughran PA; Roman LJ; Miller RT; Masters BS
Arch Biochem Biophys; 2001 Jan; 385(2):311-21. PubMed ID: 11368012
[TBL] [Abstract][Full Text] [Related]
8. Active site structure and substrate specificity of cytochrome P450 4A1: steric control of ligand approach perpendicular to heme plane.
Bambal RB; Hanzlik RP
Biochem Biophys Res Commun; 1996 Feb; 219(2):445-9. PubMed ID: 8605007
[TBL] [Abstract][Full Text] [Related]
9. P-450-dependent metabolism of lauric acid in alcoholic liver disease: comparison between rat liver and kidney microsomes.
Amet Y; Lucas D; Zhang-Gouillon ZQ; French SW
Alcohol Clin Exp Res; 1998 Apr; 22(2):455-62. PubMed ID: 9581653
[TBL] [Abstract][Full Text] [Related]
10. The omega-hydroxlyation of lauric acid: oxidation of 12-hydroxlauric acid to dodecanedioic acid by a purified recombinant fusion protein containing P450 4A1 and NADPH-P450 reductase.
Shet Ms; Fisher CW; Holmans PL; Estabrook RW
Arch Biochem Biophys; 1996 Jun; 330(1):199-208. PubMed ID: 8651697
[TBL] [Abstract][Full Text] [Related]
11. Drosophila melanogaster CYP6A8, an insect P450 that catalyzes lauric acid (omega-1)-hydroxylation.
Helvig C; Tijet N; Feyereisen R; Walker FA; Restifo LL
Biochem Biophys Res Commun; 2004 Dec; 325(4):1495-502. PubMed ID: 15555597
[TBL] [Abstract][Full Text] [Related]
12. Heteroatom substitution shifts regioselectivity of lauric acid metabolism from omega-hydroxylation to (omega-1)-oxidation.
Alterman MA; Chaurasia CS; Lu P; Hanzlik RP
Biochem Biophys Res Commun; 1995 Sep; 214(3):1089-94. PubMed ID: 7575514
[TBL] [Abstract][Full Text] [Related]
13. Expression of cytochrome P450 3A7 in Escherichia coli: effects of 5' modification and catalytic characterization of recombinant enzyme expressed in bicistronic format with NADPH-cytochrome P450 reductase.
Gillam EM; Wunsch RM; Ueng YF; Shimada T; Reilly PE; Kamataki T; Guengerich FP
Arch Biochem Biophys; 1997 Oct; 346(1):81-90. PubMed ID: 9328287
[TBL] [Abstract][Full Text] [Related]
14. Expression of rabbit cytochromes P4504A which catalyze the omega-hydroxylation of arachidonic acid, fatty acids, and prostaglandins.
Roman LJ; Palmer CN; Clark JE; Muerhoff AS; Griffin KJ; Johnson EF; Masters BS
Arch Biochem Biophys; 1993 Nov; 307(1):57-65. PubMed ID: 8239664
[TBL] [Abstract][Full Text] [Related]
15. Cloning, sequencing, and cDNA-directed expression of the rat renal CYP4A2: arachidonic acid omega-hydroxylation and 11,12-epoxidation by CYP4A2 protein.
Wang MH; Stec DE; Balazy M; Mastyugin V; Yang CS; Roman RJ; Schwartzman ML
Arch Biochem Biophys; 1996 Dec; 336(2):240-50. PubMed ID: 8954571
[TBL] [Abstract][Full Text] [Related]
16. Construction of a human cytochrome P450 1A1: rat NADPH-cytochrome P450 reductase fusion protein cDNA and expression in Escherichia coli, purification, and catalytic properties of the enzyme in bacterial cells and after purification.
Chun YJ; Shimada T; Guengerich FP
Arch Biochem Biophys; 1996 Jun; 330(1):48-58. PubMed ID: 8651703
[TBL] [Abstract][Full Text] [Related]
17. Roles of cytochrome b5 in the oxidation of testosterone and nifedipine by recombinant cytochrome P450 3A4 and by human liver microsomes.
Yamazaki H; Nakano M; Imai Y; Ueng YF; Guengerich FP; Shimada T
Arch Biochem Biophys; 1996 Jan; 325(2):174-82. PubMed ID: 8561495
[TBL] [Abstract][Full Text] [Related]
18. An enzymatically active chimeric protein containing the hydrophilic form of NADPH-cytochrome P450 reductase fused to the membrane-binding domain of cytochrome b5.
Gilep AA; Guryev OL; Usanov SA; Estabrook RW
Biochem Biophys Res Commun; 2001 Jun; 284(4):937-41. PubMed ID: 11409883
[TBL] [Abstract][Full Text] [Related]
19. In vitro hydroxylation and epoxidation of some isomeric lauric acid analogs by rat liver microsomes. Identification of metabolites and effects of clofibrate or phenobarbital pretreatment.
Boucher JL; Delaforge M; Salaün JP; Pinot F; Durst F; Pflieger P; Mioskowski C
Drug Metab Dispos; 1996 Apr; 24(4):462-8. PubMed ID: 8801062
[TBL] [Abstract][Full Text] [Related]
20. Reconstitution of the enzymatic activities of cytochrome P450s using recombinant flavocytochromes containing rat cytochrome b(5) fused to NADPH--cytochrome P450 reductase with various membrane-binding segments.
Gilep AA; Guryev OL; Usanov SA; Estabrook RW
Arch Biochem Biophys; 2001 Jun; 390(2):215-21. PubMed ID: 11396924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]